25(top 2%)
papers
1.2K(top 2%)
citations
17(top 2%)
h-index
24(top 2%)
g-index
25
all documents
1.3K
doc citations
462
citing journals

Top Articles

#TitleJournalYearCitations
1Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney CancerEuropean Urology2011422
2Going malignant: the hypoxia-cancer connection in the prostateBioEssays2002111
3Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumorsCancer Research200390
4Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical ExperienceEuropean Urology199881
5Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour modelBJU International200362
6Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-upUrology200059
7Intermittent androgen suppression for prostate cancer: rationale and clinical experienceProstate Cancer and Prostatic Diseases199851
8New developments in ureteral stent design, materials and coatingsExpert Review of Medical Devices200649
9Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinicInternational Journal of Urology200547
10Knock-down of the Cytoprotective Gene, Clusterin, to Enhance Hormone and Chemosensitivity in Prostate and Other CancersAnnals of the New York Academy of Sciences200538
11Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapyBJU International200436
12Antisense therapy: current status in prostate cancer and other malignanciesCancer and Metastasis Reviews200235
13Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft modelsCancer Chemotherapy and Pharmacology200534
14Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancerInvestigational New Drugs200227
15Development and evaluation of a prostate sexual rehabilitation clinic: a pilot projectBJU International200527
16The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumorsCancer Chemotherapy and Pharmacology200827
17Clusterin antisense complexed with chitosan for controlled intratumoral deliveryInternational Journal of Pharmaceutics200820
18Castration-induced upregulation of insulin-like growth factor binding protein-5 potentiates IGF-1 and accelerates androgen-independent progression in prostate cancerProstate Cancer and Prostatic Diseases20009
19Malignant Germ Cell Tumor of the Testis: Spontaneous Regression Of Pulmonary Metastases with 7-year SurvivalJournal of Urology19768
20The Association of Renal Pelviocaliceal Dysmorphism and Sensorineural Deafness: A New SyndromeJournal of Urology19816
21Neoadjuvant hormonal therapy prior to radical prostatectomy: promises and pitfallsProstate Cancer and Prostatic Diseases20005
22Foreign Body in the Kidney: Trans-Intestinal MigrationJournal of Urology19674
23Single‐step procedure for the radical resection of an adenocarcinoma in the deep male urethraBritish Journal of Urology19953
24Targeting anti-apoptotic genes with antisense oligodeoxy-nucleotides to delay progression to androgen independenceProstate Cancer and Prostatic Diseases19991
25Targeting Cell Survival Genes Using Antisense Oligonucleotides to Improve Chemo- and Hormonal-Therapies in Prostate CancerEuropean Urology Supplements20020